Inspire Medical Systems Inc (NYSE:INSP) reported better-than-expected third-quarter financial results and raised its FY25 GAAP EPS results above estimates on Monday.

Inspire Medical Systems reported quarterly earnings of 38 cents per share which beat the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $224.501 million which beat the analyst consensus estimate of $220.467 million.

Inspire Medical Systems raised its FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.90-$1.00 and affirmed sales guidance of $900.000 million-$910.000 million.

“The Inspire team had a very productive third quarter focusing on the transition to the Inspire V system while delivering very strong results globally,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. “Further, at recent industry meetings, we presented clinical evidence demonstrating that the Inspire V system offers enhanced performance, building on the strong foundation established by our legacy systems.”

Inspire Medical shares jumped 17% to trade at $86.46 on Tuesday.

These analysts made changes to their price targets on Inspire Medical following earnings announcement.

Considering buying INSP stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Says Stay Away From AT&T, Calls Nextracker ‘Tremendous’

Photo via Shutterstock